News and
Events

Curesponse shows applicability with next generation immuno-oncology drugs

Curesponse to exhibit at ASCO, 2022

Curesponse to present at BIOMED Israel, 2022

Nature Cancer

Curesponse publishes new clinical study in Nature Cancer

GlobeNewswire

Curesponse and Rafael announce collaboration

Channel 13

Curesponse interviewed on Israel Channel 13

GlobeNewswire

Curesponse secures additional USD 8 Million funding

Curesponse presents positive interim results at AACR 2021

themarker

Curesponse featured in the Marker (in Hebrew)

Geektime

Curesponse raises USD $ 6 million (in Hebrew)

Want to know more?

Contact Us